Emerald Advisers’s Kite Pharma, Inc. KITE Stock Holding History

Emerald Advisers’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-37,250	Closed	-$1.08M	–	432
2014 Q2	$1.08M	Buy	+37,250	New	+$1.11M	0.06%	247

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Emerald Advisers's KITE Position: Q3 2014 in Review

Emerald Advisers sold out of Kite Pharma, Inc. (KITE) in Q3 2014, closing a stake of 37,250 shares — an estimated $1.08M sold.

Emerald Advisers first reported a position in KITE in Q2 2014 and held it in 1 quarter. The position peaked at $1.08M in Q2 2014. 62 funds tracked by Wall St. Rank hold KITE as of Q3 2014.

Emerald Advisers reported no remaining Kite Pharma, Inc. position as of Q3 2014 after selling out during the quarter.
Emerald Advisers sold 37,250 Kite Pharma, Inc. shares in Q3 2014, an estimated $1.08M.
Emerald Advisers first reported a position in Kite Pharma, Inc. in Q2 2014 and held it in 1 quarter.
Emerald Advisers's Kite Pharma, Inc. position peaked at $1.08M in Q2 2014.
62 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2014.

Based on Emerald Advisers's 13F filing for Q3 2014, filed 28 Oct 2014.